A compendium of successful case studies of FAMILY PLANNING implementation in India This is the first book on innovations in family planning service delivery in the country which is of particular contemporary relevance, both nationally and globally.It features innovative case studies of family planning from India which have demonstrated impact and are sustainable and scalable. These cases contribute to the approaches of problem solving, enhancing quality family planning care at the grass-roots level and influence future directions of the programme. The book facilitates advocacy, strengthening programme design and enhancing competency as well as orienting the healthcare system to support these efforts. This is an important book for programme planners, policy makers and researchers.

This report summarizes presentations and discussions at the Workshop on the Social Processes Underlying Fertility Change in Developing Countries, organized by the Committee on Population of the National Research Council (NRC) in Washington, D.C., January 29-30, 1998. Fourteen papers were presented at the workshop; they represented both theoretical and empirical perspectives and shed new light on the role that diffusion processes may play in fertility transition. These papers served as the basis for the discussion that is summarized in this report.

There are numerous reasons to hasten the introduction of new and improved contraceptivesâ€"from health concerns about the pill to the continuing medical liability crisis. Yet, U.S. organizations are far from taking a leadership position in funding, researching, and introducing new contraceptivesâ€"in fact, the United States lags behind Europe and even some developing countries in this field. Why is research and development of contraceptives stagnating? What must the nation do to energize this critical arena? This book presents an overall examination of contraceptive development in the United Statesâ€"covering research, funding, regulation, product liability, and the effect of public opinion. The distinguished authoring committee presents a blueprint for substantial change, with specific policy recommendations that promise to gain the attention of specialists, the media, and the American public. The highly readable and well-organized volume will quickly become basic reading for legislators, government agencies, the pharmaceutical industry, private organizations, legal professionals, and researchersâ€"everyone concerned about family planning, reproductive health, and the impact of the liability and regulatory systems on scientific innovations.